Found 105 matching trials
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
PHASE1RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Vaccine Therapy in Treating Patients With Melanoma
PHASE2RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma
PHASE1RATIONALE: Inserting a gene that has been created in the laboratory into a ...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
PHASE2This experiment will test the safety and effectiveness of a treatment for m...
Location
National Cancer Institute (NCI)
Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma
PHASE2This randomized pilot phase II trial studies how well vaccine therapy works...
Location
Providence Portland Medical Center
Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.
EARLY_PHASE1Gliomas are a heterogeneous group of tumors arising from glial cells in the...
Location
Biogenea Pharmaceuticals Ltd
Vaccine Therapy in Treating Patients With Metastatic Melanoma
PHASE2RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
PHASE3The purpose of this study is to evaluate the efficacy and safety of tebenta...
Location
Mayo Clinic Arizona
Melanoma Vaccine With Peptides and Leuprolide
PHASE2The goal of this clinical research study is to learn if the drug leuprolide...
Location
UT MD Anderson Cancer Center
A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
PHASE1IMCgp100-102 is a Phase I/II study of the weekly intra-patient escalation d...
Location
University California, San Diego Moores Cancer Center